BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22118971)

  • 1. [Concordance between FRAX and Fracture Index in the prediction of the risk of osteoporosis-associated fracture in postmenopausal women].
    Sastre García JF; Carbayo García JJ; Criado-Álvarez JJ; López MB
    Med Clin (Barc); 2012 Mar; 138(5):225-6. PubMed ID: 22118971
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year fracture risk in the assessment of osteoporosis management efficacy in postmenopausal women: a pilot study.
    Pluskiewicz W; Drozdzowska B; Adamczyk P
    Climacteric; 2013 Feb; 16(1):117-26. PubMed ID: 22335356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it time for treat to target strategy in osteoporosis?
    Chapurlat R
    Joint Bone Spine; 2016 Jul; 83(4):381-3. PubMed ID: 26875064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison fracture risk calculated by FRAX tool].
    Carranza-Lira S; Lanuza-López MC; Sandoval-Barragán MP
    Ginecol Obstet Mex; 2014 Sep; 82(9):591-4. PubMed ID: 25412552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to identifying osteopenic women at increased short-term risk of fracture.
    Miller PD; Barlas S; Brenneman SK; Abbott TA; Chen YT; Barrett-Connor E; Siris ES
    Arch Intern Med; 2004 May; 164(10):1113-20. PubMed ID: 15159269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologizing old age: the case of osteoporosis.
    Grob GN
    MD Advis; 2011; 4(2):20-2, 24-7. PubMed ID: 21637178
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteoporosis knowledge in patients with a first fragility fracture in Puerto Rico.
    Díaz-Correa LM; Ramírez-García LM; Castro-Santana LE; Vilá LM
    Bol Asoc Med P R; 2014; 106(1):6-10. PubMed ID: 24791357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute versus relative fracture risk.
    Johnston CC; Hui S
    J Bone Miner Res; 2005 Apr; 20(4):704; author reply 705. PubMed ID: 15765190
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatology and osteoporosis (RETOSS): a vision of postmenopausal osteoporosis in rheumatology departments throughout Spain].
    Bernad Pineda M; González Fernández CM; Fernández Prada M; Fernández Campillo J; Maeso Martín R; Garcés Puentes MV
    Reumatol Clin; 2011; 7(1):13-9. PubMed ID: 21794774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
    Gold DT; Martin BC; Frytak JR; Amonkar MM; Cosman F
    Curr Med Res Opin; 2007 Mar; 23(3):585-94. PubMed ID: 17355739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal osteoporosis.
    Diab DL; Watts NB
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):501-9. PubMed ID: 24150190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fractures in the elderly].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1997 Jun; 34(6):451-2. PubMed ID: 9301258
    [No Abstract]   [Full Text] [Related]  

  • 17. FRAX and its applications in health economics--cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example.
    Ström O; Borgström F; Kleman M; McCloskey E; Odén A; Johansson H; Kanis JA
    Bone; 2010 Aug; 47(2):430-7. PubMed ID: 20493983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoporosis].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2010 Jan; 6(231):56-60, 62. PubMed ID: 20196435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
    Novak S
    Reumatizam; 2008; 55(2):75-7. PubMed ID: 19024282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive approach to fragility fractures.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.